Search
for
Sort by
Research 481–510 of 1000+
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue
- The Role of 5αR Inhibitors in the Early Growth of Pca Cells
- A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil
- Most Baricitinib Responders Achieved Full Scalp Hair Regrowth: Findings from Adult and Paediatric BRAVE-AA Trials
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Laser hair removal
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Selective Expression of Calcium-Binding Proteins S100A8 and S100A9 at Distinct Sites of Hair Follicles
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Module-based complexity formation: periodic patterning in feathers and hairs
- GATA3 inhibits proliferation and induces expression of both early and late differentiation markers in keratinocytes of the human epidermis
- Abstracts
- Pharmacological Treatment of Alopecia
- Effectiveness and safety of oral Janus kinase inhibitors in patients aged ≤12 with alopecia areata: a systematic review and meta-analysis
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies
- Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures
- 873 The effect of Cilostazol on hair growth: A novel therapeutic option for the treatment of hair loss
- The 5α-reductase inhibitor finasteride reduces opioid self-administration
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Targets to treat androgen excess in polycystic ovary syndrome